Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 4, 2010, Pages 669-675

  Lee, Sang Guk ^a   Lee, Hyukmin ^a,b   Jeong, Seok Hoon ^a   Yong, Dongeun ^a   Chung, Gyung Tae ^c   Lee, Yeong Seon ^c   Chong, Yunsop ^a   Lee, Kyungwon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Korea Centers for Disease Control and Prevention   (South Korea)

Author keywords

Antibiotic resistance; Cephalosporins; Genotyping; Penicillin binding protein 2

Indexed keywords

CEFIXIME; CEFTRIAXONE; PENICILLIN BINDING PROTEIN 2A; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; BACTERIAL DNA; BACTERIAL PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; GENE MUTATION; GENOTYPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MTRR GENE; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PENA GENE; PILQ GENE; PONA GENE; PORB GENE; BACTERIUM IDENTIFICATION; CHEMISTRY; DNA FINGERPRINTING; DNA SEQUENCE; DRUG EFFECT; GENETICS; KOREA; MICROBIOLOGICAL EXAMINATION; MISSENSE MUTATION; MOLECULAR GENETICS;

ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CEFIXIME; CEFTRIAXONE; DNA FINGERPRINTING; DNA, BACTERIAL; GENOTYPE; HUMANS; KOREA; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEISSERIA GONORRHOEAE; SEQUENCE ANALYSIS, DNA;

EID: 77952570638     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp505     Document Type: Article

References (27)

1. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther 2006; 4: 619-28.
2. Centers for Disease Control andPrevention(CDC).Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 2007; 56: 332-6.
3. Australian Gonococcal Surveillance Programme. Annual report of the Australian Gonococcal Surveillance Programme, 2005. Commun Dis Intell 2006; 30: 205-10.
4. Ameyama S, Onodera S, Takahata M et al. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother 2002; 46: 3744-9.
5. Ilina EN, Vereshchagin VA, Borovskaya AD et al. Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains. Antimicrob Agents Chemother 2008; 52: 2175-82.
6. Lindberg R, Fredlund H, Nicholas R et al. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother 2007; 51: 2117-22.
7. Martin IM, Hoffmann S, Ison CA. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother 2006; 58: 587-93.
8. Takahata S, Senju N, Osaki Y et al. Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 2006; 50: 3638-45.
9. Tanaka M, Nakayama H, Huruya K et al. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype. Int J Antimicrob Agents 2006; 27:20-6.
10. Wang SA, Lee MV, O'Connor N et al. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001. Clin Infect Dis 2003; 37: 849-52.
11. Whiley DM, Limnios EA, Ray S et al. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother 2007; 51: 3111-6.
12. Lo JY, Ho KM, Leung AO et al. Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection. Antimicrob Agents Chemother 2008; 52: 3564-7.
13. Ito M, Deguchi T, Mizutani KS et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan. Antimicrob Agents Chemother 2005; 49: 137-43.
14. Deguchi T, Yasuda M, Yokoi S et al. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J Infect Chemother 2003; 9:35-9.
15. Ropp PA, Hu M, Olesky M et al. Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002; 46: 769-77.
16. Zhao S, Tobiason DM, Hu M et al. The penC mutation conferring antibiotic resistance in Neisseria gonorrhoeae arises from a mutation in the PilQ secretin that interferes with multimer stability. Mol Microbiol 2005; 57: 1238-51.
17. Zhao S, Duncan M, Tomberg J et al. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2009; 53: 3744-51.
18. Dowson CG, Jephcott AE, Gough KR et al. Penicillin-binding protein 2 genes of non-b-lactamase-producing, penicillin-resistant strains of Neisseria gonorrhoeae. Mol Microbiol 1989; 3: 35-41.
19. Dougherty TJ. Genetic analysis and penicillin-binding protein alterations in Neisseria gonorrhoeae with chromosomally mediated resistance. Antimicrob Agents Chemother 1986; 30: 649-52.
20. Whiley DM, Limnios EA, Ray S et al. Further questions regarding the role of mosaic penA sequences in conferring reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2007; 51: 802-3.
21. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Seventh Edition: Approved Standard M7-A7. CLSI, Wayne, PA, USA, 2006.
22. Liao M, Bell K, Gu WM et al. Clusters of circulating Neisseria gonorrhoeae strains and association with antimicrobial resistance in Shanghai. J Antimicrob Chemother 2008; 61: 478-87.
23. Martin IM, Ison CA, Aanensen DM et al. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis 2004; 189: 1497-505.
24. Osaka K, Takakura T, Narukawa K et al. Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. J Infect Chemother 2008; 14: 195-203.
25. Tapsall J, Whiley D, Sloots T. Applications of molecular testing in clinical laboratories for the diagnosis and control of gonorrhea. Future Microbiol 2006; 1: 317-24.
26. Wong WW, Huang CT, Li LH et al. Molecular epidemiological identification of Neisseria gonorrhoeae clonal clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis. J Clin Microbiol 2008; 46: 3931-4.
27. Hagman KE, Shafer WM. Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae. J Bacteriol 1995; 177: 4162-5.